CERIA THERAPEUTICS
Ceria Therapeutics is a preclinical biotechnology company that focuses on developing innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing.
CERIA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2019-01-01
Address:
Aurora, Colorado, United States
Country:
United States
Website Url:
http://www.ceriatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
9492460875
Email Addresses:
[email protected]
Similar Organizations
CHEC PR
CHEC PR has developed orally available peptide compounds for cell degeneration due to inflammation, oxidative stress or protein.
Current Employees Featured
Official Site Inspections
http://www.ceriatherapeutics.com
- Host name: 193.0.153.160.host.secureserver.net
- IP address: 160.153.0.193
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ceria Therapeutics"
About - Ceria Therapeutics
LEADERSHIP TEAM Dr. Liechty is the Company founder and inventor of the product. He is Professor of Surgery at Children’s Hospital Colorado, Anschutz Medical Campus, Aurora, Colorado, Director of Pediatric Surgery Basic and …See details»
Ceria Therapeutics - Crunchbase Company Profile
Ceria Therapeutics is a preclinical biotechnology company that focuses on developing innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing.See details»
Ceria Therapeutics - LinkedIn
Ceria was founded to develop products from a proprietary platform technology to treat life-threatening human diseases characterized by overactive and dysregulated immune responses.See details»
CERIA THERAPEUTICS INC - VentureRadar
Website: https://www.ceriatherapeutics.com. Develops innovative therapies targeting inflammatory disorders, addressing conditions like ARDS, IBD, and DFU, to enhance natural …See details»
CERIA THERAPEUTICS INC - VentureRadar
Website: https://www.ceriatherapeutics.com. Develops nanoparticle-based microRNA therapeutics for unregulated inflammatory conditions. Has research facilities in Tucson, …See details»
Contact - Ceria Therapeutics
OUR ADDRESS. Ceria Therapeutics, Inc 1230 N Cherry Ave, BSRL 329 Tucson, AZ 85721See details»
Ceria Therapeutics - Products, Competitors, Financials, Employees ...
About Ceria Therapeutics. Ceria Therapeutics focuses on the development of drug products for inflammatory disorders. The company's main offerings include drugs designed to regulate …See details»
Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to
Jan 22, 2024 The award will go towards the development of CTX-001 in preparation for clinical studies. Tucson, AZ – January 20, 2024 – Ceria Therapeutics, Inc. (Ceria), an Arizona-based …See details»
Ceria Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Ceria Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD …
Tucson, AZ – October 3, 2023 – Ceria Therapeutics, Inc. (Ceria), an Arizona-based biotech startup focusing on the development of novel therapeutics to address several inflammatory diseases, today announced that the company …See details»
Ceria Therapeutics, Inc. - BIO International Convention | BIO
Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Skip to main …See details»
Ceria Therapeutics, Inc. Awarded a $2,100,000 SBIR Grant to
Sep 19, 2023 The award will go towards the development of CTX-002 in preparation for clinical studies. Tucson, AZ – September 19, 2023 – Ceria Therapeutics, Inc. (Ceria), an Arizona …See details»
Ceria-based nanotheranostic agent for rheumatoid arthritis - PMC
Oct 25, 2020 Introduction. RA is a long-term, progressive disease characterized by chronic inflammation within the synovial tissues in multiple joints (synovitis), leading to increscent and …See details»
Our Science - Ceria Therapeutics
Our first products utilize a miRNA-146a conjugated cerium oxide nanoparticle [CNP-miR146a] as the active pharmaceutical agent. The miR146a component blocks key genes in the …See details»
Our Focus - Ceria Therapeutics
ARDS. Acute Respiratory Distress Syndrome [ARDS] is a severe and life-threatening lung condition. ARDS is characterized by rapid onset of widespread inflammation in the lungs …See details»
Ceria Therapeutics - YouTube
Ceria Therapeutics has a novel platform for micro-RNA delivery. Our cerium oxide nanoparticles are conjugated to a micro-Ribonucleic Acid (miRNA) via a propr...See details»
Pipeline - Ceria Therapeutics
Stay connected with us. Stay connected with us. ©2024 Ceria TherapeuticsSee details»
News - Ceria Therapeutics
$8.6 million Advanced Industries Awards Accelerate 36 Colorado Start-ups: Ceria Therapeutics, Inc. – Aurora, CO $250,000 – CTx is developing a pipeline of drug products based on a single …See details»